Clinical Trials Logo

Clinical Trial Summary

Febrile seizures (FS) are the most common neurological disorder in chilhood. The etiology of FN is still the subject of numerous studies and it is known that it can depend on genetic predisposition.


Clinical Trial Description

Febrile seizures (FS) are the most common neurological disorder in chilhood. It is precisely because of the high incidence of the disease, the age that includes the tendency of repetition, represent a particular challenge in pediatric practice. FS, as defined by the American Academy of Pediatrics (AAP), are " seizure occurring in febrile children between the ages of 6 and 60 months who do not have an intracranial infection, metabolic disturbance, or history of afebrile seizures ". Simple febrile seizure is defined as a short (<15 min) generalized seizure, not repeat within 24 h, that occurs during a febrile illness not resulting from an acute disease of the nervous system in a child aged between 6 months and 5 years, with no neurologic deficits and no previous afebrile seizures. Complex febrile seizures are a focal, or generalized and prolonged seizure, of a duration of greater than 15 min, recurring more than once in 24 h, and/or associated with postictal neurologic abnormalities, more frequently a postictal palsy (Todd's palsy), or with previous neurologic deficits. The etiology of FN is still the subject of numerous studies and it is known that it can depend on genetic predisposition. Animal studies have shown that mice without the KCC2 gene have frequent generalized seizures, while those with heterozygous deletion of the KCC2 gene have a reduced threshold for seizure onset. In the human population, mutations of this gene have been reported in children with FN as well as in children with epilepsy. There is no examined an association between polymorphism rs2297201 KCC2 gene and FS. Studies have shown an association between TRPV1 genes and the appearance of FS in experimental models, however, similar studies in the human population have not been done so far. Studies Moria et al. 2012 showed that polymorphism rs222797 TRPV1 gene involve the regulation of human cortical excitability, glutamate transmission and increased neuronal excitability. The C allele this polymorphism is associated with a greater maximal response to the caspaicin and anadamine agonists. All of this indicate that changes TRPV1 gene that lead to increased channel function may suggest a predisposition for FS. Since FS are genetically controlled, we want to determine the association of TRPV1 and KCC2 gene polymorphisms with the occurrence of FN. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04368936
Study type Observational [Patient Registry]
Source Institut za Rehabilitaciju Sokobanjska Beograd
Contact
Status Completed
Phase
Start date March 31, 2015
Completion date August 2021

See also
  Status Clinical Trial Phase
Completed NCT03481764 - Anthropogenetic Variability in the Group of Individuals With Febrile Seizures
Not yet recruiting NCT05008458 - Value of Von Willebrand Factor and Copeptin Assay in Children With Febrile Seizures at Sohag University Hospital
Completed NCT01694524 - Nervous System Infections Among Patients With Febrile Seizure N/A
Not yet recruiting NCT05947006 - Study of the Impact of a Pediatric Nurse's Consultation on Parental Anxiety During a Febrile Convulsion in Children N/A
Recruiting NCT05215366 - Value of Copeptin Assay in Children With Febrile Seizures at Sohag University Hospital
Completed NCT03165981 - Fever After Simultaneous Versus Sequential Vaccination in Young Children Phase 4
Completed NCT04967066 - A Cross-Sectional Study of Serum Levels of Adipocytokines in Children With Febrile Seizures
Terminated NCT01370044 - Carbon Dioxide (Carbogen) for the Treatment of Febrile Seizures Phase 2/Phase 3